Nurse Practitioner in Mt. Morris, PA Accepting Medicare
1 Nurse Practitioner nurses found. Showing 1 - 1
 Melany D Chrash, CRNP-C Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 104 Front St., Mt. Morris, PA 15349 Phone: 724-324-9001 |
News Archive
Seroquel is significantly more effective than placebo in treating patients with rapid-cycling bipolar disorder
AstraZeneca has announced important new data at the 4th European Stanley Foundation Conference on Bipolar Disorder, which show Seroquel is significantly more effective than placebo in treating patients with rapid-cycling bipolar disorder and is also well-tolerated in this difficult to treat patient population.
First-ever Prophylactic Cancer Vaccine Conference to be held in Tempe, Arizona
World-leading scientists, ethicists, policymakers, and cancer patient advocates will gather at Arizona State University for the first-ever Prophylactic Cancer Vaccine Conference in Tempe, Ariz., March 16-18, 2011. The conference will be a premier forum to discuss the latest developments in a radical new approach to battling cancer: the development of cancer vaccines aimed at protecting healthy individuals from the disease.
Over quarter million women who gave birth in hospitals had pre-existing diabetes or developed gestational diabetes
More than a quarter million women who gave birth in U.S. hospitals in 2008 had pre-existing diabetes or developed it during their pregnancy - a condition called gestational diabetes, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. This equals 6.4 percent of the 4.2 million women who gave birth in that year.
JAMA commentary argues that vitamin therapy still plays a role in reducing stroke
A commentary by Dr. David Spence of The University of Western Ontario and Dr. Meir Stampfer of the Harvard School of Public Health in today's Journal of the American Medical Association (JAMA) argues that vitamin therapy still has a role to play in reducing stroke.
CBio recruits 75th patient into XToll phase II clinical trial, achieves milestone under agreement with Novo Nordisk
Australian drug development company CBio Limited today announced the achievement of a clinical trial milestone under its option agreement with global pharmaceutical leader Novo Nordisk A/S. The agreement relates to the development of XToll, the potential new-generation drug therapy which could provide safer and more effective treatment of autoimmune diseases such as rheumatoid arthritis (RA).
› Verified 2 days ago